| Mr Clifton D Loyd, PA-C | |
|
Usameddac,wuerzburg, Unit 26610, Us Army Health Clinic-wuerzburg, Apo, AE 09244 | |
| (093) 180-43 | |
| Not Available |
| Full Name | Mr Clifton D Loyd |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | Usameddac,wuerzburg, Unit 26610, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538237441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 1034707 (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Clifton D Loyd, PA-C Usameddac Wuerzburg, Unit 26610, Credentials Office, Apo, AE 09244 Ph: () - | Mr Clifton D Loyd, PA-C Usameddac,wuerzburg, Unit 26610, Us Army Health Clinic-wuerzburg, Apo, AE 09244 Ph: (093) 180-43 |
News Archive
Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress.
Media outlets report on the varying views on the waivers granted so far by the Obama administration to ease requirements of the health law. Meanwhile, specific regulations — such as those relating to the "broker rule" and accountable care organizations — continue to be hot topics.
MaxID Pty Ltd, a wholly owned company of MaxID Corp, a leading provider of mobile identity solutions, is pleased to announce that it has won a 1000-unit sale of its iDL500 units in South Africa.
Ohm Laboratories, Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis.
Towers Watson, a leading global professional services company, today announced the completion of its acquisition of Extend Health, Inc., which operates the largest private Medicare exchange in the United States.
› Verified 9 days ago
Jeffrey Robert Hartzell, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 86 Mdg, Unit 3215, Ramstein Ab, Apo, AE 09094 Phone: 314-480-4758 | |
Mr. Francis Edward Criss Jr., PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Hq, Meddac Bavaria, Unit 28037 Bldg 700, Apo, AE 09112 Phone: 910-907-8922 | |
Jason Mommaerts, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg, Unit 3215, Apo, AE 09094 Phone: 314-480-7520 | |
Ms. Nancy Marie Giunta, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: Lrmc, Cmr 402, Box 1917, Apo, AE 09180 Phone: 486-820-2 | |
Ms. Karyn Elizabeth Kagel, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 3310,0, Apo, AE 09180 Phone: 314-542-3918 | |
Brandon Burt, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Us Army Meddac Bavaria, Cmr 411, Bldg 700, Rm 41, Apo, AE 09112 Phone: 734-787-1619 | |
Sean Kelly, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Cmr 411 Box 2507, Apo, AE 09112 Phone: 216-990-2375 |